143 related articles for article (PubMed ID: 34413108)
1. Health care utilisation preceding relapse or second malignant neoplasm after childhood acute lymphoblastic leukaemia: a population-based matched cohort study.
Jensen KS; Klug Albertsen B; Schrøder H; Zalounina Falborg A; Schmiegelow K; Rosthøj S; Callesen MT; Vedsted P
BMJ Open; 2021 Aug; 11(8):e050285. PubMed ID: 34413108
[TBL] [Abstract][Full Text] [Related]
2. Health care utilisation following childhood acute lymphoblastic leukaemia: a population-based matched cohort study.
Jensen KS; Klug Albertsen B; Schrøder H; Zalounina Falborg A; Schmiegelow K; Rosthøj S; Callesen MT; Vedsted P
BMJ Open; 2021 Nov; 11(11):e049847. PubMed ID: 34810184
[TBL] [Abstract][Full Text] [Related]
3. Secondary malignant neoplasms after intensive treatment of relapsed acute lymphoblastic leukaemia in childhood.
Borgmann A; Zinn C; Hartmann R; Herold R; Kaatsch P; Escherich G; Möricke A; Henze G; von Stackelberg A;
Eur J Cancer; 2008 Jan; 44(2):257-68. PubMed ID: 17981026
[TBL] [Abstract][Full Text] [Related]
4. Risk of late effects of treatment in children newly diagnosed with standard-risk acute lymphoblastic leukaemia: a report from the Childhood Cancer Survivor Study cohort.
Essig S; Li Q; Chen Y; Hitzler J; Leisenring W; Greenberg M; Sklar C; Hudson MM; Armstrong GT; Krull KR; Neglia JP; Oeffinger KC; Robison LL; Kuehni CE; Yasui Y; Nathan PC
Lancet Oncol; 2014 Jul; 15(8):841-51. PubMed ID: 24954778
[TBL] [Abstract][Full Text] [Related]
5. Excess morbidity and mortality among survivors of childhood acute lymphoblastic leukaemia: 25 years of follow-up from the United Kingdom Childhood Cancer Study (UKCCS) population-based matched cohort.
Kane E; Kinsey S; Bonaventure A; Johnston T; Simpson J; Howell D; Smith A; Roman E
BMJ Open; 2022 Mar; 12(3):e056216. PubMed ID: 35256445
[TBL] [Abstract][Full Text] [Related]
6. Incidence, Risk Factors, and Mortality Associated With Second Malignant Neoplasms Among Survivors of Adolescent and Young Adult Cancer.
Chao C; Bhatia S; Xu L; Cannavale KL; Wong FL; Huang PS; Cooper R; Armenian SH
JAMA Netw Open; 2019 Jun; 2(6):e195536. PubMed ID: 31173129
[TBL] [Abstract][Full Text] [Related]
7. Second malignant neoplasms: an increasingly recognized complication of childhood cancer.
Ariffin H; Ariffin WA; Chan LL; Lam SK; Lin HP
Med J Malaysia; 1997 Jun; 52(2):174-7. PubMed ID: 10968078
[TBL] [Abstract][Full Text] [Related]
8. Healthcare utilisation in general practice and hospitals in the year preceding a diagnosis of cancer recurrence or second primary cancer: a population-based register study.
Rasmussen LA; Jensen H; Virgilsen LF; Falborg AZ; Møller H; Vedsted P
BMC Health Serv Res; 2019 Dec; 19(1):941. PubMed ID: 31805930
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetically based dosing of thiopurines in childhood acute lymphoblastic leukemia: influence on cure rates and risk of second cancer.
Levinsen M; Rotevatn EØ; Rosthøj S; Nersting J; Abrahamsson J; Appell ML; Bergan S; Bechensteen AG; Harila-Saari A; Heyman M; Jonsson OG; Maxild JB; Niemi M; Söderhäll S; Schmiegelow K;
Pediatr Blood Cancer; 2014 May; 61(5):797-802. PubMed ID: 24395436
[TBL] [Abstract][Full Text] [Related]
10. Reduced Morbidity and Mortality in Survivors of Childhood Acute Lymphoblastic Leukemia: A Report From the Childhood Cancer Survivor Study.
Dixon SB; Chen Y; Yasui Y; Pui CH; Hunger SP; Silverman LB; Ness KK; Green DM; Howell RM; Leisenring WM; Kadan-Lottick NS; Krull KR; Oeffinger KC; Neglia JP; Mertens AC; Hudson MM; Robison LL; Armstrong GT; Nathan PC
J Clin Oncol; 2020 Oct; 38(29):3418-3429. PubMed ID: 32706634
[TBL] [Abstract][Full Text] [Related]
11. Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemia.
Hijiya N; Hudson MM; Lensing S; Zacher M; Onciu M; Behm FG; Razzouk BI; Ribeiro RC; Rubnitz JE; Sandlund JT; Rivera GK; Evans WE; Relling MV; Pui CH
JAMA; 2007 Mar; 297(11):1207-15. PubMed ID: 17374815
[TBL] [Abstract][Full Text] [Related]
12. Utilisation of primary care before a childhood cancer diagnosis: do socioeconomic factors matter?: A Danish nationwide population-based matched cohort study.
Friis Abrahamsen C; Ahrensberg JM; Vedsted P
BMJ Open; 2018 Aug; 8(8):e023569. PubMed ID: 30121615
[TBL] [Abstract][Full Text] [Related]
13. The changing burden of long-term health outcomes in survivors of childhood acute lymphoblastic leukaemia: a retrospective analysis of the St Jude Lifetime Cohort Study.
Mulrooney DA; Hyun G; Ness KK; Bhakta N; Pui CH; Ehrhardt MJ; Krull KR; Crom DB; Chemaitilly W; Srivastava DK; Relling MV; Jeha S; Green DM; Yasui Y; Robison LL; Hudson MM
Lancet Haematol; 2019 Jun; 6(6):e306-e316. PubMed ID: 31078468
[TBL] [Abstract][Full Text] [Related]
14. Second malignancies in patients treated for childhood acute lymphoblastic leukemia.
Kimball Dalton VM; Gelber RD; Li F; Donnelly MJ; Tarbell NJ; Sallan SE
J Clin Oncol; 1998 Aug; 16(8):2848-53. PubMed ID: 9704738
[TBL] [Abstract][Full Text] [Related]
15. Detection mode of childhood acute lymphoblastic leukaemia relapse and its effect on survival: a Nordic population-based cohort study.
Jensen KS; Oskarsson T; Lähteenmäki PM; Flaegstad T; Schmiegelow K; Vedsted P; Albertsen BK; Schrøder H;
Br J Haematol; 2021 Aug; 194(4):734-744. PubMed ID: 34041748
[TBL] [Abstract][Full Text] [Related]
16. Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983.
Bhatia S; Sather HN; Pabustan OB; Trigg ME; Gaynon PS; Robison LL
Blood; 2002 Jun; 99(12):4257-64. PubMed ID: 12036851
[TBL] [Abstract][Full Text] [Related]
17. Late relapsing childhood lymphoblastic leukemia.
Vora A; Frost L; Goodeve A; Wilson G; Ireland RM; Lilleyman J; Eden T; Peake I; Richards S
Blood; 1998 Oct; 92(7):2334-7. PubMed ID: 9746771
[TBL] [Abstract][Full Text] [Related]
18. A nationwide register-study of healthcare utilisation in the year preceding a colorectal cancer recurrence diagnosis.
Rasmussen LA; Jensen H; Falborg AZ; Iversen LH; Vedsted P
Eur J Cancer Care (Engl); 2021 Nov; 30(6):e13494. PubMed ID: 34291857
[TBL] [Abstract][Full Text] [Related]
19. Neuroblastoma survivors are at increased risk for second malignancies: A report from the International Neuroblastoma Risk Group Project.
Applebaum MA; Vaksman Z; Lee SM; Hungate EA; Henderson TO; London WB; Pinto N; Volchenboum SL; Park JR; Naranjo A; Hero B; Pearson AD; Stranger BE; Cohn SL; Diskin SJ
Eur J Cancer; 2017 Feb; 72():177-185. PubMed ID: 28033528
[TBL] [Abstract][Full Text] [Related]
20. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
